Cancer associated with aging

Cancer is an age-related disease.

Our focus is aging

Our risk of cancer increases significantly after age 50, and half of all cancers occur at age 66 and above. Buck scientists are studying aging processes linked to cancer and are developing treatments to prevent or treat cancers, with a special emphasis on breast cancer. Our expertise ranges from the lab bench to the bedside. We are even studying the impact of chemotherapy as a driver of secondary cancers.

Chris Benz, MD

Professor
Read more

Pierre-Yves Desprez PhD

Professor in Residence
Read more

Francesca E. Duncan, PhD

Associate Professor in Residence
Read more

Birgit Schilling, PhD

Professor
Read more

Eric Verdin, MD

President and Chief Executive Officer, Professor
Read more

Collaborating with the Buck

Learn more about how your company can work with Buck science and technology.

Learn more